Anterior Gradient 2 Antibody

About the Target

Anterior Gradient 2 (AGR2) is a developmentally regulated thioredoxin-like, estrogen-responsive secreted protein belonging to the protein disulfide isomerase (PDI) family, with critical roles in protein folding, cellular homeostasis, and cancer progression. AGR2 is expressed in various tissues and is regulated by estrogen, with particularly high levels during mammary gland development. Depending on the literature source, AGR2 may also be discussed as Anterior Gradient 2 and AG-2.

Reported cellular context includes endoplasmic reticulum and secreted, which can matter when signal is compared across treatments or changing cell states. Following AGR2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.

Research Context

AGR2 is commonly interpreted in the context of cancer and oxidative stress research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans endoplasmic reticulum and secreted, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between endoplasmic reticulum and secreted across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• redox-associated shifts that may alter abundance, localization, or pathway coupling
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for AGR2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in AGR2 reflect biology rather than handling. When interpreting AGR2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep AGR2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.